Core Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Core Laboratories has a total shareholder equity of $245.7M and total debt of $147.6M, which brings its debt-to-equity ratio to 60.1%. Its total assets and total liabilities are $597.8M and $352.1M respectively. Core Laboratories's EBIT is $55.4M making its interest coverage ratio 4.1. It has cash and short-term investments of $17.7M.
Key information
60.1%
Debt to equity ratio
US$147.62m
Debt
| Interest coverage ratio | 4.1x |
| Cash | US$17.70m |
| Equity | US$245.69m |
| Total liabilities | US$352.11m |
| Total assets | US$597.80m |
Recent financial health updates
Recent updates
We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt
Jul 15
These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong
Jun 25It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year
May 02Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?
Mar 26Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price
Mar 02Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts
Nov 09Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture
Sep 08Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up
Aug 16Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors
Jul 05The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence
May 25Financial Position Analysis
Short Term Liabilities: CLB's short term assets ($233.5M) exceed its short term liabilities ($97.6M).
Long Term Liabilities: CLB's short term assets ($233.5M) do not cover its long term liabilities ($254.5M).
Debt to Equity History and Analysis
Debt Level: CLB's net debt to equity ratio (52.9%) is considered high.
Reducing Debt: CLB's debt to equity ratio has reduced from 151.2% to 60.1% over the past 5 years.
Debt Coverage: CLB's debt is well covered by operating cash flow (28.4%).
Interest Coverage: CLB's interest payments on its debt are well covered by EBIT (4.1x coverage).